Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. Nowadays, available therapies for MS can help to manage MS course and symptoms, but new therapeutic approaches are required. Stem cell therapy using mesenchymal stem cells (MSCs) appeared promising in diff...
Main Authors: | Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8662 |
Similar Items
-
Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
by: Thangavelu Soundara Rajan, et al.
Published: (2020-05-01) -
Advances in Mesenchymal Stem Cell Therapy for Osteoarthritis: From Preclinical and Clinical Perspectives
by: Zehui Lv, et al.
Published: (2023-02-01) -
Could the Heat Shock Proteins 70 Family Members Exacerbate the Immune Response in Multiple Sclerosis? An in Silico Study
by: Luigi Chiricosta, et al.
Published: (2020-06-01) -
Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
by: Asma Alanazi, et al.
Published: (2022-12-01) -
Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration
by: Agnese Gugliandolo, et al.
Published: (2021-12-01)